MXPA03001510A - Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. - Google Patents
Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof.Info
- Publication number
- MXPA03001510A MXPA03001510A MXPA03001510A MXPA03001510A MXPA03001510A MX PA03001510 A MXPA03001510 A MX PA03001510A MX PA03001510 A MXPA03001510 A MX PA03001510A MX PA03001510 A MXPA03001510 A MX PA03001510A MX PA03001510 A MXPA03001510 A MX PA03001510A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- production
- methods
- medicaments containing
- bicyclic heterocycles
- Prior art date
Links
- 125000002618 bicyclic heterocycle group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10042061A DE10042061A1 (en) | 2000-08-26 | 2000-08-26 | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
PCT/EP2001/009535 WO2002018370A1 (en) | 2000-08-26 | 2001-08-18 | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03001510A true MXPA03001510A (en) | 2003-06-09 |
Family
ID=7653948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03001510A MXPA03001510A (en) | 2000-08-26 | 2001-08-18 | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1315716A1 (en) |
JP (1) | JP2004507533A (en) |
AU (1) | AU2001289814A1 (en) |
CA (1) | CA2417042A1 (en) |
DE (1) | DE10042061A1 (en) |
MX (1) | MXPA03001510A (en) |
WO (1) | WO2002018370A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813014A (en) | 2002-03-28 | 2008-03-16 | Astrazeneca Ab | Quinazoline derivatives |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
US20040044014A1 (en) | 2002-04-19 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
DE10217689A1 (en) * | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
AU2004253967B2 (en) | 2003-07-03 | 2010-02-18 | Cytovia, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
GB0317665D0 (en) | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Qinazoline derivatives |
BRPI0414489A8 (en) | 2003-09-16 | 2019-01-15 | Astrazeneca Ab | quinazoline derivative, pharmaceutical composition, use of a quinazoline derivative, and process for the preparation of a quinazoline derivative |
EP1667992B1 (en) | 2003-09-19 | 2007-01-24 | Astrazeneca AB | Quinazoline derivatives |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
TW200640904A (en) | 2005-02-26 | 2006-12-01 | Astrazeneca Ab | Quinazoline derivatives |
EP1921070A1 (en) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation |
EP2118075A1 (en) | 2007-02-06 | 2009-11-18 | Boehringer Ingelheim International GmbH | Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
RS52573B (en) | 2008-02-07 | 2013-04-30 | Boehringer Ingelheim International Gmbh | Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
EP2303276B1 (en) | 2008-05-13 | 2013-11-13 | AstraZeneca AB | Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline |
CA2733153C (en) | 2008-08-08 | 2016-11-08 | Boehringer Ingelheim International Gmbh | Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
US8507502B2 (en) | 2008-11-10 | 2013-08-13 | National Health Research Institutes | Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
ES2773693T3 (en) * | 2010-06-09 | 2020-07-14 | Tianjin Hemay Oncology Pharmaceutical Co Ltd | Cyanoquinoline derivatives |
CN102382106A (en) * | 2010-08-30 | 2012-03-21 | 黄振华 | Aniline substituted quinazoline derivative |
KR101317809B1 (en) | 2011-06-07 | 2013-10-16 | 한미약품 주식회사 | Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cell and non-metalic salt lubricant |
KR20140096571A (en) | 2013-01-28 | 2014-08-06 | 한미약품 주식회사 | Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one |
SG11202102981SA (en) | 2018-09-25 | 2021-04-29 | Black Diamond Therapeutics Inc | Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
-
2000
- 2000-08-26 DE DE10042061A patent/DE10042061A1/en not_active Withdrawn
-
2001
- 2001-08-18 MX MXPA03001510A patent/MXPA03001510A/en unknown
- 2001-08-18 CA CA002417042A patent/CA2417042A1/en not_active Abandoned
- 2001-08-18 JP JP2002523885A patent/JP2004507533A/en active Pending
- 2001-08-18 AU AU2001289814A patent/AU2001289814A1/en not_active Abandoned
- 2001-08-18 WO PCT/EP2001/009535 patent/WO2002018370A1/en not_active Application Discontinuation
- 2001-08-18 EP EP01969610A patent/EP1315716A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2004507533A (en) | 2004-03-11 |
WO2002018370A1 (en) | 2002-03-07 |
CA2417042A1 (en) | 2002-03-07 |
DE10042061A1 (en) | 2002-03-07 |
EP1315716A1 (en) | 2003-06-04 |
AU2001289814A1 (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03001483A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
AU2001295481A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2001287694A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
IL147133A0 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof | |
MXPA03001510A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof. | |
MXPA03000873A (en) | Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof. | |
MXPA03005018A (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use. | |
MXPA03005019A (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use. | |
AU6383101A (en) | Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them | |
HUS1400005I1 (en) | Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof | |
AU2002219173A1 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
PL366794A1 (en) | Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments | |
ZA200201494B (en) | Benzodiazepin derivatives, the production and use thereof. | |
ZA200107989B (en) | 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof. | |
AU2003226806A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof | |
IL150377A0 (en) | Substituted piperidines, medicaments containing these compounds, and methods for the production thereof | |
AU2001241056A1 (en) | Spiro compounds, process for preparing the same and use thereof as drugs | |
IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
ZA200110351B (en) | Bycyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof. | |
MXPA03007550A (en) | Caloporoside derivatives, methods for the production thereof and their use. | |
IL162562A (en) | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines | |
MXPA03008636A (en) | Isoquinuclidine derivative, process for producing the same, and medicinal composition containing the same. | |
HU0001178D0 (en) | New propene-carbon acid-amidoxim derivatives, process for their production and medicaments containing the same | |
SI1372670T1 (en) | Caloporoside derivatives, methods for the production thereof and their use |